Park et al. [4] identified six independent risk factors influencing the prognosis of patients with stage I GC, which include age over 65 years, male, stage IB, lymphovascular invasion, perineural invasion, and an elevated carcinoembryonic antigen level. Here, CEACAM5 is linked to gastric cancer.